Mutational Spectrum of Multiple Endocrine Neoplasia Type 2 and Sporadic Medullary Thyroid Carcinoma in Taiwan

被引:11
作者
Chang, Chin-Feng [3 ,6 ]
Yang, Wei-Shiung [1 ,4 ,5 ,6 ]
Su, Yi-Ning [2 ,4 ,6 ]
Wu, I-Ling [1 ,6 ]
Chang, Tien-Chun [1 ,5 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei 100, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan
[4] Natl Taiwan Univ, Grad Inst Clin Med, Taipei 10764, Taiwan
[5] Natl Taiwan Univ, Dept Med, Taipei 10764, Taiwan
[6] Natl Taiwan Univ, Genet Counseling Program, Inst Mol Med, Coll Med, Taipei 10764, Taiwan
关键词
human; multiple endocrine neoplasia type 2A; multiple endocrine neoplasia type 2B; mutation; RET protein; thyroid neoplasms; RET PROTOONCOGENE MUTATIONS; PROPHYLACTIC THYROIDECTOMY; NEUROENDOCRINE TUMORS; KOREAN FAMILIES; 2A; CANCER; MANAGEMENT; DIAGNOSIS; CODON-634; CHILDREN;
D O I
10.1016/S0929-6646(09)60084-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Purpose: Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant cancer predisposition syndrome, and >95% of MEN 2 patients carry rearranged during transfection (RET) protooncogene mutants. We aimed to elucidate the genotype and phenotype relationship of RET proto-oncogene mutations in Taiwanese subjects with medullary thyroid cancer (MTC). Methods: We genotyped the MEN-2-associated germ-line mutations by PCR-based sequencing of the RET gene. DNA was extracted from a total of 69 members from eight unrelated families with individuals affected by MTC, and from seven sporadic cases of MTC. Results: RET mutations were found in four MEN 2A families, all at codon 634 (one with C > R, two with C > r, and one with C > W). One MEN 2A patient carried a de novo mutation at codon 634 (C > R). In two families of MEN 213, all carried the mutation at codon 918 (M > T). These two cases of MEN 2B were all de novo mutations. One family of familial MTC or unclassified MEN 2 carried the codon 620 (C > F) mutation. Among the seven sporadic cases of MTC, none was found to carry any mutation in hotspot exons. Only two non-synonymous variants (T278N/exon 4 and D489N/exon 7) were found in two cases. However, these two variants were not uncommon in our elderly population. Conclusion: We found that all eight MTC patients with a family history or with the other phenotypes of MEN 2 had RET mutations, whereas no significant RET mutation was found in seven patients with isolated MTC without family history and other endocrine diseases. Molecular scanning of the RET gene in MEN 2 and MTC in Taiwanese patients probably should be limited to exons 10, 11 and 16, initially to be costeffective. [J Formos Med Assoc 2009;108(5):402-408]
引用
收藏
页码:402 / 408
页数:7
相关论文
共 45 条
[1]   RET and NTRK1 proto-oncogenes in human diseases [J].
Albert, L ;
Carniti, C ;
Miranda, C ;
Roccato, E ;
Pierotti, MA .
JOURNAL OF CELLULAR PHYSIOLOGY, 2003, 195 (02) :168-186
[2]   RET tyrosine kinase signaling in development and cancer [J].
Arighi, E ;
Borrello, MG ;
Sariola, H .
CYTOKINE & GROWTH FACTOR REVIEWS, 2005, 16 (4-5) :441-467
[3]   Inheritable forms of medullary thyroid carcinoma [J].
Bachelot, A ;
Lombardo, F ;
Baudin, E ;
Bidart, JM ;
Schlumberger, M .
BIOCHIMIE, 2002, 84 (01) :61-66
[4]   A rare extracellular D631Y germline mutation of the RET proto-oncogene in two Korean families with multiple endocrine neoplasia 2A [J].
Bae, Sung Jin ;
Kim, Dae-Jung ;
Kim, Ji Youn ;
Park, So Young ;
Choo, Sung Hee ;
Song, Young Duk ;
Ki, Chang-Seok ;
Chung, Jae Hoon .
THYROID, 2006, 16 (06) :609-614
[5]  
Blank RD, 1996, CANCER, V78, P1996, DOI 10.1002/(SICI)1097-0142(19961101)78:9<1996::AID-CNCR22>3.3.CO
[6]  
2-5
[7]  
Boikos SA, 2008, HISTOL HISTOPATHOL, V23, P109, DOI 10.14670/HH-23.109
[8]   Guidelines for diagnosis and therapy of MEN type 1 and type 2 [J].
Brandi, ML ;
Gagel, RF ;
Angeli, A ;
Bilezikian, JP ;
Beck-Peccoz, P ;
Bordi, C ;
Conte-Devolx, B ;
Falchetti, A ;
Gheri, RG ;
Libroia, A ;
Lips, CJM ;
Lombardi, G ;
Mannelli, M ;
Pacini, F ;
Pondder, BAJ ;
Raue, F ;
Skogseid, B ;
Tamburrano, G ;
Thakker, RV ;
Thompson, NW ;
Tomassetti, P ;
Tonelli, F ;
Wells, SA ;
Marx, SJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (12) :5658-5671
[9]   Multiple endocrine neoplasia syndrome: genetic basis for clinical management [J].
Carling, T .
CURRENT OPINION IN ONCOLOGY, 2005, 17 (01) :7-12
[10]   Familial multiple endocrine neoplasia - The first 100 years [J].
Carney, JA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (02) :254-274